Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Vertex Pharmaceuticals (VRTX ... With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

Vertex also has multiple other catalysts on the way in 2025 and over the next few years. It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could ...

Sometimes, a stock has a potential catalyst right around the corner. In such a case, investors could be much better off buying sooner rather than later. What's so special about Jan. 30 for Vertex?

Ola Electric Share Price Live Updates: Ola Electric closed at ₹75.65 on last trading day & the technical trend suggests Bearish near term outlook ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.72% to $416.96 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.21 ...

This readout is viewed as a significant potential catalyst for Vertex's stock, as success in chronic pain could substantially expand the market opportunity for the company's pain franchise. Vertex's ...

This readout is viewed as a significant potential catalyst for Vertex's stock, as success in chronic pain could substantially expand the market opportunity for the company's pain franchise.